148 related articles for article (PubMed ID: 38087999)
21. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma.
Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K
Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
[TBL] [Abstract][Full Text] [Related]
23. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
Li C; Song W; Zhang J; Luo Y
Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
[TBL] [Abstract][Full Text] [Related]
24. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
[TBL] [Abstract][Full Text] [Related]
25. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
Guo J; Tong C; Shi J; Li X; Chen X
Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
[TBL] [Abstract][Full Text] [Related]
26. Construction of a Novel Mitochondria-Associated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival.
Wang X; Zhang Z; Shi Y; Zhang W; Su C; Wang D
J Microbiol Biotechnol; 2024 May; 34(5):1164-1177. PubMed ID: 38719775
[TBL] [Abstract][Full Text] [Related]
27. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
29. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma.
Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW
Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
[TBL] [Abstract][Full Text] [Related]
31. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
32. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
33. Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration.
Nie Y; Yao G; Xu X; Liu Y; Yin K; Lai J; Li Q; Zhou F; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1155009. PubMed ID: 37025404
[TBL] [Abstract][Full Text] [Related]
34. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y
World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985
[TBL] [Abstract][Full Text] [Related]
35. Expression of IDO1 in Tumor Microenvironment Significantly Predicts the Risk of Recurrence/Distant Metastasis for Patients With Esophageal Squamous Cell Carcinoma.
Qiu C; Lin Q; Ji S; Han C; Yang Q
Lab Invest; 2023 Dec; 103(12):100263. PubMed ID: 37839637
[TBL] [Abstract][Full Text] [Related]
36. Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma.
Zhang D; Qian C; Wei H; Qian X
Front Mol Biosci; 2020; 7():599475. PubMed ID: 33381521
[No Abstract] [Full Text] [Related]
37. Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment.
Cui Y; Hou R; Lv X; Wang F; Yu Z; Cui Y
Front Oncol; 2021; 11():771749. PubMed ID: 34760708
[TBL] [Abstract][Full Text] [Related]
38. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.
Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y
Front Immunol; 2023; 14():1117658. PubMed ID: 36817484
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.
Zhou Y; Chu L; Li S; Chu X; Ni J; Jiang S; Pang Y; Zheng D; Lu Y; Lan F; Cai X; Yang X; Zhu Z
Cancer Immunol Immunother; 2024 Jun; 73(8):141. PubMed ID: 38832974
[TBL] [Abstract][Full Text] [Related]
40. Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma.
Zhao F; Li Y; Dong Z; Zhang D; Guo P; Li Z; Li S
Front Cell Dev Biol; 2022; 10():845293. PubMed ID: 35646892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]